Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2042475
Abstract: Abstract Background to find clinical features that can predict prognosis in patients with oligometastatic disease treated with stereotactic body radiotherapy (SBRT) Material and methods Patients with less than 5 metastases in less than 3 different… read more here.
Keywords: disease treated; oligometastatic disease; body; treated stereotactic ... See more keywords
Survival impact of aggressive treatment on patients with oligometastatic non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e20669
Abstract: e20669Background: The new 2016lung cancer classification differentiates oligometastatic (M1b) better prognostic from plurimetastatic (M1c) disease. A prospective study presented at 2016 ASCO showed improved PFS in patients with oligometastatic brain disease treated aggressively compared to… read more here.
Keywords: treatment; disease; lung cancer; cancer ... See more keywords
Cost-effectiveness analysis of stereotactic ablative radiotherapy in patients with oligometastatic cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.7085
Abstract: 7085Background: The SABR-COMET randomized clinical trial found that stereotactic ablative radiotherapy (SABR) improved outcomes among cancer patients with oligometastatic disease. Yet, the cost of ... read more here.
Keywords: ablative radiotherapy; cancer; stereotactic ablative; cost effectiveness ... See more keywords
Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic Prostate Cancer
Sign Up to like & getrecommendations! Published in 2019 at "In Vivo"
DOI: 10.21873/invivo.11495
Abstract: Background/Aim: The aim of this study was to analyze the prognostic impact of biomarkers, such as serum lactate dehydrogenase (LDH), in patients with oligometastatic castration-resistant prostate cancer, arbitrarily defined as a maximum of five metastatic… read more here.
Keywords: contribution serum; biomarkers prognostic; serum biomarkers; prostate cancer ... See more keywords
First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.766066
Abstract: Objective The aim of this study was to investigate the efficacy and safety of combined applications of local consolidative radiation therapy (LCRT) and first-line tyrosine kinase inhibitors (TKIs) for the treatment of primary tumors and… read more here.
Keywords: elderly patients; activating mutations; egfr activating; first line ... See more keywords